TRIA BIOSCIENCE CORPORATION

Company Information
Address 1616 EASTLAKE AVE E
STE 260
SEATTLE, WA, -

http://triabioscience.com

Information

DUNS: 831016907

# of Employees: 7


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Vaccine Adjuvant for Rapid Tolerance Induction in Allergy Patients

    Amount: $579,383.00

    DESCRIPTION (provided by applicant): Allergy is a major cause of illness and disability with an estimated 40-50 million people afflicted in the US alone. AIT provides long-term benefits for the patien ...

    SBIRPhase I2013Department of Health and Human Services
  2. Cross-Protective Monoclonal Antibodies for treatment of pandemic Flu

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Influenza is a highly contagious respiratory disease that causes substantial mortality world-wide. There is great international concern that the Avian Influenza v ...

    SBIRPhase I2012Department of Health and Human Services
  3. Advanced Design of a Nicotine Vaccine for Smoking Cessation

    Amount: $352,841.00

    DESCRIPTION (provided by applicant): Tobacco smoke is the primary cause of lung cancer, cardiovascular disease and premature death, with nearly 5 million people dying each year. Treatments that preven ...

    SBIRPhase I2012Department of Health and Human Services
  4. Protective vaccine for H5N1 Flu using H5 protein and a novel TLR4 agonist.

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bird populations world-wide and t ...

    SBIRPhase II2011Department of Health and Human Services
  5. A novel DC-targeting non-integrating lentivector vaccine for HIV infection

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Despite two decades of persistent research on prophylactic and therapeutic immunization against HIV, an effective vaccine-based solution to the HIV pandemic has re ...

    SBIRPhase I2010Department of Health and Human Services
  6. Pandemic H5N1 vaccine containing recombinant H5 and a synthetic TLR4 agonist, GLA

    Amount: $756,444.00

    DESCRIPTION (provided by applicant): H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bird populations world-wide and t ...

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government